Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Small Cell Lung Cancer Extensive Stage

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital of Sichuan University, Sichuan, China
Contact: Study coordinator (You Lu)

Study leads

You Lu
Principal Investigator
West China Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

SCLC · SCLC, Extensive Stage · SCLC, Limited Stage

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Shenyang, China

First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Small Cell Lung Cancer Extensive Stage

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Chengdu, China